logo
Plus   Neg
Share
Email

Abbott, Tandem Diabetes Care Partner To Develop Integrated Diabetes Solutions

Abbott (ABT) and Tandem Diabetes Care (TNDM) have finalized an agreement to develop and commercialize integrated diabetes solutions that combine Abbott's continuous glucose monitoring technology with Tandem's insulin delivery systems. The companies will focus initial commercial activities in the U.S. and Canada with additional geographies considered in the future.

Jared Watkin, senior vice president, Diabetes Care, Abbott, said: "By combining our glucose sensing technology with Tandem's insulin delivery systems, we will be able to create a cohesive ecosystem for people with diabetes that can fit easily into their daily lives."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Department of Health and Human Services or HHS said it has secured most of the supply of COVID-19 drug remdesivir through September. The deal would allow American hospitals to purchase the antiviral drug in allocated amounts amid the spike in confirmed cases each day. HHS Secretary Alex Azar said, "President Trump has struck an amazing deal to ensure Americans have access to the first..." Novartis AG (NVS) agreed to pay $678 million to settle U.S. government charges it paid illegal kickbacks to doctors to induce them to prescribe its cardiovascular and diabetes drugs, the U.S. Department of Justice said in a statement. PG&E Corp. (PCG) said Wednesday that it has emerged from Chapter 11 bankruptcy protection, after implementing its financial restructuring plan that was previously approved by the U.S. Bankruptcy Court and state regulators.
Follow RTT